NextWave Pharmaceuticals, Inc
13 drugs in NADAC|0 Generic,13 Brand
NextWave Pharmaceuticals, Inc lists 13 NDCs in the CMS NADAC file (0 generic, 13 brand), at an average NADAC of $8.93 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
13
0G / 13B
Avg Price / Unit
$8.9300
$1.80 – $14.81
Avg 7d Change
-0.05%
Across 11 drugs with changes
7d Activity
of 13 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
methylphenidate hydrochloride market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Central Nervous System Stimulant therapeutic class
Review the broader class where NextWave Pharmaceuticals, Inc has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does NextWave Pharmaceuticals, Inc make?
NextWave Pharmaceuticals, Inc lists 13 NDCs in the CMS NADAC file — 0 generic and 13 brand products.
What is the average price of NextWave Pharmaceuticals, Inc drugs?
The average NADAC across NextWave Pharmaceuticals, Inc's portfolio is $8.9300 per unit, ranging from $1.8006 to $14.8065.
What types of drugs does NextWave Pharmaceuticals, Inc make?
NextWave Pharmaceuticals, Inc makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Central Nervous System Stimulant (12), Central alpha-2 Adrenergic Agonist (1).
Has NextWave Pharmaceuticals, Inc had any drug recalls?
No FDA enforcement recalls are matched to NextWave Pharmaceuticals, Inc in the openFDA feed.
How has NextWave Pharmaceuticals, Inc's pricing changed recently?
Over the past 7 days, 4 NextWave Pharmaceuticals, Inc products rose and 7 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DYANAVEL XR 15 MG TABLET amphetamine | $14.8065 per EA | +0.03% |
DYANAVEL XR 20 MG TABLET amphetamine | $14.7895 per EA | -0.26% |
DYANAVEL XR 10 MG TABLET amphetamine | $14.7783 per EA | -0.07% |
ONYDA XR 0.1 MG/ML SUSPENSION Clonidine hydrochloride | $13.3796 per ML | +0.02% |
QUILLICHEW ER 20 MG CHEW TAB methylphenidate hydrochloride | $11.9002 per EA | -0.06% |
QUILLICHEW ER 30 MG CHEW TAB methylphenidate hydrochloride | $11.8844 per EA | -0.03% |
QUILLICHEW ER 40 MG CHEW TAB methylphenidate hydrochloride | $11.8720 per EA | -0.05% |
DYANAVEL XR 5 MG TABLET amphetamine | $7.8534 per EA | +0.04% |
QUILLIVANT XR 25 MG/5 ML SUSP methylphenidate hydrochloride | $5.3962 per ML | 0.00% |
DYANAVEL XR 2.5 MG/ML SUSP amphetamine | $2.7674 per ML | +0.03% |
QUILLIVANT XR 25 MG/5 ML SUSP methylphenidate hydrochloride | $2.7009 per ML | -0.02% |
QUILLIVANT XR 25 MG/5 ML SUSP methylphenidate hydrochloride | $2.1612 per ML | 0.00% |
QUILLIVANT XR 25 MG/5 ML SUSP methylphenidate hydrochloride | $1.8006 per ML | -0.14% |